ライフサイエンスコーパス: bloodstream infection

1 llowing: pocket infection; endocarditis; and bloodstream infection.

2 estinal malignancy, yet are also isolated in bloodstream infection.

3 rt-term mortality in patients with S. aureus bloodstream infection.

4 isional surgical site infection, and primary bloodstream infection.

5 There were no cases of cannula-related bloodstream infection.

6 stantial burden of arterial catheter-related bloodstream infection.

7 tor-associated pneumonia or catheter-related bloodstream infection.

8 the prevalence of arterial catheter-related bloodstream infection.

9 and S. marcescens occurred closer to time of bloodstream infection.

10 an underrecognized cause of catheter-related bloodstream infection.

11 reduce the risk of arterial catheter-related bloodstream infection.

12 i as the sole pathogen in a catheter-related bloodstream infection.

13 ing the empirical treatment of patients with bloodstream infection.

14 uitable treatment in patients with S. aureus bloodstream infection.

15 mia, but TLR2(-/-)mice could still resolve a bloodstream infection.

16 83 for intra-abdominal infection and 45 for bloodstream infection.

17 tant clone associated with urinary tract and bloodstream infections.

18 omising approach for combating P. aeruginosa bloodstream infections.

19 nd their role in the management of pediatric bloodstream infections.

20 ulatory system, capable of causing S. aureus bloodstream infections.

21 how this interaction impacts the outcome of bloodstream infections.

22 lin-susceptible Staphylococcus aureus (MSSA) bloodstream infections.

23 spective multicenter cohort of P. aeruginosa bloodstream infections.

24 portant and widely used diagnostic assay for bloodstream infections.

25 ol that offers a new paradigm for diagnosing bloodstream infections.

26 or-associated pneumonia and catheter-related bloodstream infections.

27 e for a high proportion of urinary tract and bloodstream infections.

28 on making for patients with life-threatening bloodstream infections.

29 identification of organisms responsible for bloodstream infections.

30 to the prevention of central line-associated bloodstream infections.

31 tion about the role of PhoQ in P. aeruginosa bloodstream infections.

32 ens associated with trauma-related wound and bloodstream infections.

33 studies providing data for catheter-related bloodstream infections.

34 ention decreased mortality for patients with bloodstream infections.

35 etecting microorganisms that cause pediatric bloodstream infections.

36 I-TOF with AST intervention in patients with bloodstream infections.

37 ; 85.7% were HACO infections, and 93.2% were bloodstream infections.

38 ylococcus isolates were not considered to be bloodstream infections.

39 pirical antibiotic therapy in the setting of bloodstream infections.

40 al therapy-related outcomes in patients with bloodstream infections.

41 cteria and yeasts in patients with suspected bloodstream infections.

42 s to reduce the risk for catheter-associated bloodstream infections.

43 nd outcomes of rapidly growing mycobacterial bloodstream infections.

44 f MDROs and development of hospital-acquired bloodstream infections.

45 or the most commonly identified organisms in bloodstream infections.

46 improved clinical outcomes for patients with bloodstream infections.

47 nts with less frequent Gram-negative bacilli bloodstream infections.

48 surface decolonisation reduced all-pathogen bloodstream infections.

49 t (ICU) patients may affect catheter-related bloodstream infections.

50 mine a worse outcome both in respiratory and bloodstream infections.

51 theters (hazard ratio [HR] for time to first bloodstream infection 0.71, 95% CI 0.37-1.34).

52 ected as the source for the catheter-related bloodstream infection (0.70/1,000 catheter days).

53 lator-days; p < 0.001), and catheter-related bloodstream infections (1.0 vs 3.5 per 1,000 catheter-da

54 nd soft tissue infections than in nosocomial bloodstream infections (11.1% versus 5.6%, respectively;

55 group B, there were 53% fewer gram-positive bloodstream infections (15% [9 of 60] vs 32% [19 of 60];

56 We tested 616 bloodstream infection, 185 pneumonia, and 110 sterile fl

57 were driveline infections (47%), followed by bloodstream infections (24% VAD related, and 22% non-VAD

58 = .03) and 64% fewer central line-associated bloodstream infections (3.4 vs 9.4 per 1000 central line

59 P < .001) and more frequently manifested as bloodstream infection (31% vs 6%; P = .002).

60 Of the 114 adult patients, 27 had bloodstream infections, 36 had localized infections, and

61 Of 11 children with late-onset neonatal bloodstream infections, 7 produced at least 1 stool that

62 rrently the reference standard for detecting bloodstream infection, a multistep process which may tak

63 Intensive care unit cost per bloodstream infection accounted for the largest share of

64 cloacae isolated between 2001 and 2011 from bloodstream infections across hospitals in the UK and Ir

65 Patients with C. glabrata bloodstream infection admitted to a large, tertiary care

66 ntion significantly reduced catheter-related bloodstream infection after large-scale implementation i

67 ly from the blood of patients with suspected bloodstream infections aids in diagnosis and guides trea

68 remain the leading cause of catheter-related bloodstream infection, although an increase in Gram-nega

69 CVCs can also be a source of bloodstream infections, although this risk is not well u

70 n for empiric and definitive therapy of MSSA bloodstream infections among patients admitted to 122 ho

71 We report long-term trends in bloodstream infection and antimicrobial resistance from

72 in patients at high risk of catheter-related bloodstream infection and central venous catheter or art

73 To compare catheter-related bloodstream infection and colonization risk between the

74 riking benefit for bacterial survival during bloodstream infection and dissemination to other tissues

75 al of 314 propensity score-matched S. aureus bloodstream infection and in 268 E. coli bloodstream inf

76 ally invades normally sterile sites to cause bloodstream infection and meningitis.

77 measure was a composite of catheter-related bloodstream infection and symptomatic deep-vein thrombos

78 rization was associated with a lower risk of bloodstream infection and symptomatic thrombosis and a h

79 ated vascular devices can act as a nidus for bloodstream infection and systemic pathogen disseminatio

80 tion and, more importantly, catheter-related bloodstream infection and warrants routine use in patien

81 cation of Gram-negative organisms that cause bloodstream infections and can significantly impact pati

82 (ICUs) resulted in greater reductions in all bloodstream infections and clinical isolates of methicil

83 ated clinical infection syndromes (including bloodstream infections and community-acquired pneumonia)

84 used as rescue therapy for complicated MRSA bloodstream infections and deserves further clinical eva

85 are divided into anatomic systems, including Bloodstream Infections and Infections of the Cardiovascu

86 ntact is associated with fewer gram-positive bloodstream infections and possible central line-associa

87 chlorhexidine may prevent hospital-acquired bloodstream infections and the acquisition of multidrug-

88 res ordered, and the cumulative incidence of bloodstream infections and ventilator-associated pneumon

89 rtile range, 9-36 days), 61% of patients had bloodstream infection, and 59% died.

90 ssociated pneumonia, central line-associated bloodstream infection, and catheter-associated urinary t

91 ality, lengths of hospitalization, recurrent bloodstream infections, and 30-day hospital readmissions

92 All but 1 case-patient had bloodstream infections, and 6 presented with sepsis.

93 most common cause of central-line-associated bloodstream infections, and antibiotic resistance makes

94 ulture contamination, health care-associated bloodstream infections, and rates of the primary outcome

95 arge proportion of E. coli urinary tract and bloodstream infections, and they differ markedly in thei

96 Bloodstream infections are a leading cause of morbidity

97 Fungal bloodstream infections are a significant problem in the

98 Catheter-related bloodstream infections are associated with significant c

99 Even with surgical and antibiotic therapy, bloodstream infections are associated with significant m

100 Infections acquired overseas and bloodstream infections are particularly important areas

101 , 0.29 [95% CI, 0.10-0.82]; P = .02) and new bloodstream infection (ARR, 0.05 [95% CI, 0.00-0.09]; RR

102 e optimal preventive strategies for reducing bloodstream infections associated with arterial catheter

103 udies have shown that the occurrence rate of bloodstream infections associated with arterial catheter

104 median estimates of the incidence density of bloodstream infections associated with arterial catheter

105 We report 4 bloodstream infections associated with CC9 agr type II S

106 wed records of all patients with C. glabrata bloodstream infection at Duke Hospital over the past dec

107 d susceptible K. pneumoniae isolates causing bloodstream infections at a tertiary care hospital in Ne

108 Staphylococcus aureus bloodstream infection (bacteremia) is a major cause of m

109 For patients with MSSA bloodstream infections, beta-lactams are superior to van

110 The primary outcome was time to first bloodstream infection between 48 h after randomisation a

111 condary outcomes including hospital-acquired bloodstream infections, blood culture contamination, or

112 We present bloodstream infection (BSI) and meningitis surveillance

113 s for vancomycin-resistant enterococci (VRE) bloodstream infection (BSI) are limited.

114 from hospital-admitted patients suspected of bloodstream infection (BSI) in 4 of 11 provinces in DRC

115 nce of beta-lactam resistance in VGS causing bloodstream infection (BSI) in neutropenic patients.

116 antifungal regimen for Candida parapsilosis bloodstream infection (BSI) in view of its reduced susce

117 The risk for Staphylococcus aureus bloodstream infection (BSI) is increased in immunocompro

118 We examined P. aeruginosa bloodstream infection (BSI) isolates for the ability to

119 Bloodstream infection (BSI) to due vancomycin-resistant

120 The occurrence of bloodstream infection (BSI), defined as a bacterial infe

121 nt Staphylococcus aureus (MRSA) carriage and bloodstream infection (BSI), which shows a male predomin

122 vancomycin dosing on patient outcome in MRSA bloodstream infection (BSI); (2) defining, testing, and

123 Candida bloodstream infections (BSI) are associated with signifi

124 illin-resistant Staphylococcus aureus (MRSA) bloodstream infections (BSI) are classified epidemiologi

125 organism identification improves outcomes in bloodstream infections (BSI) but have not controlled for

126 Candida species are common causes of bloodstream infections (BSI), with high mortality.

127 ntification of bacteria for the diagnosis of bloodstream infections (BSI).

128 ndida and multidrug-resistant (MDR) bacteria bloodstream infections (BSIs) and their crude death rate

129 in hospital-onset (HO) Staphylococcus aureus bloodstream infections (BSIs) and used whole-genome sequ

130 whether rising incidence rates of nosocomial bloodstream infections (BSIs) caused by antibiotic-resis

131 nation therapy on mortality of patients with bloodstream infections (BSIs) due to CPE.

132 ta-lactamase inhibitors for the treatment of bloodstream infections (BSIs) due to extended-spectrum b

133 Yet, its impact on MRSA bloodstream infections (BSIs) has not been well studied.

134 We investigated Bcc bloodstream infections (BSIs) in a cohort of non-CF pati

135 Information on community-acquired bacterial bloodstream infections (BSIs) in individuals infected wi

136 the treatment of gram-negative bacilli (GNB) bloodstream infections (BSIs) in patients presenting wit

137 f blood culture (BC) volume for detection of bloodstream infections (BSIs) is documented.

138 To determine the magnitude of bloodstream infections (BSIs) related to their use, PubM

139 In March 2011, Serratia marcescens bloodstream infections (BSIs) were identified in 5 patie

140 Among 170 isolates causing true bloodstream infections (BSIs), significantly more Staphy

141 Staphylococci are a frequent cause of bloodstream infections (BSIs).

142 ly demonstrate improved clinical outcomes in bloodstream infections (BSIs).

143 for multidrug-resistant Enterococcus faecium bloodstream infections (BSIs).

144 Cs) are the standard method for diagnosis of bloodstream infections (BSIs).

145 theters are recommended for adults to reduce bloodstream infections but not for children because ther

146 tream infection were similar to those of all bloodstream infections, but the difference was not signi

147 neutropenia, likely bacterial infection, and bloodstream infection by >/=70%.

148 We show here that the R domain enables bloodstream infections by directing fibrinogen to the st

149 ur knowledge, these are the first reports of bloodstream infections by Trichosporon inkin in patients

150 ering of blood cultures and the incidence of bloodstream infections calls into question the importanc

151 S. aureus bloodstream infection cases and controls were equally ma

152 nfections (i.e., central-catheter-associated bloodstream infection, catheter-associated urinary tract

153 Community-acquired bloodstream infections cause substantial morbidity and m

154 therapy failed in a neutropenic patient with bloodstream infection caused by a DAP-susceptible Entero

155 ort the case of a patient from Brazil with a bloodstream infection caused by a strain of methicillin-

156 taphylococci and protect mice against lethal bloodstream infections caused by a broad spectrum of MRS

157 patients with sepsis or septic shock due to bloodstream infections caused by GNB admitted between 20

158 ovel possibilities of treating or preventing bloodstream infections caused by pathogenic Gram negativ

159 acetylsalicylic acid therapy on mortality in bloodstream infections caused by S. aureus compared with

160 k for developing central catheter-associated bloodstream infections (CCABSIs) owing to children's chr

161 We describe central line-associated bloodstream infection (CLABSI) pathogens and antimicrobi

162 increase the risk of central line-associated bloodstream infections (CLABSIs) are not fully understoo

163 e was a composite of central line-associated bloodstream infections (CLABSIs), catheter-associated ur

164 ealthcare-associated central line-associated bloodstream infections (CLABSIs), using National Healthc

165 k therapy to prevent central line-associated bloodstream infections (CLABSIs), we performed a systema

166 catheters significantly reduced the risk of bloodstream infections compared with standard and hepari

167 percent of children experienced at least one bloodstream infection, corresponding to 5.11 (95% CI, 4.

168 in severe sepsis/septic shock, patients with bloodstream infection could be discriminated by a decrea

169 A catheter-related bloodstream infection (CRBSI) was suspected in 44 (58%)

170 linically diagnosed sepsis, catheter-related bloodstream infection (CRBSI), and all-cause mortality.

171 r complications of HPN were catheter-related bloodstream infections (CRBSIs) (1.7/1000 d of PN) and i

172 e parenteral support (HPS), catheter-related bloodstream infections (CRBSIs) inflict health impairmen

173 Catheter-related bloodstream infections decreased from 2.38 to 0.73 infec

174 receiver operating characteristic curve for bloodstream infection diagnosis was significantly greate

175 pid identification of microorganisms causing bloodstream infections directly from a positive blood cu

176 ed assay can rapidly detect F. tularensis in bloodstream infections directly in whole blood at the ea

177 pacting definitive antimicrobial therapy for bloodstream infections due to these organisms.

178 ut bloodstream infection or catheter-related bloodstream infection during the ICU stay.

179 Frequency of enterococcal bloodstream infection (E-BSI) is increasing, and the num

180 ith increased incidence of enteric bacterial bloodstream infections (EB-BSI), this association has no

181 ropriate antibiotic therapy for enterococcal bloodstream infections (EBSI) can be delayed.

182 In two patients, an attenuated toxicity bloodstream infection evolved from an asymptomatically c

183 Current evidence on catheter-related bloodstream infection femoral risk, compared with the ot

184 total hospital costs decreased by $2,439 per bloodstream infection, for an approximate annual cost sa

185 reducing rates of MRSA clinical isolates and bloodstream infection from any pathogen.

186 rmed a post hoc analysis of patients with PA bloodstream infections from a published prospective coho

187 ction and decrease risk of hospital-acquired bloodstream infection (HABSI).

188 By 24 months postimplementation, the rate of bloodstream infection had fallen 25.5% and was 15.1% low

189 Active surveillance for bloodstream infections has been conducted in two rural T

190 Interventions to reduce hospital-acquired bloodstream infection have succeeded in reducing rates i

191 apable of infecting human beings and causing bloodstream infections have been identified.

192 he primary endpoint in patients with E. coli bloodstream infection (hazard ratio, 0.78; 95% CI, 0.40-

193 scharged home (all p</=0.002); had decreased bloodstream infection, hospital-acquired pressure ulcer,

194 aureus (MRSA) is a frequent cause of lethal bloodstream infection; however, vaccines and antibody th

195 ica is a leading cause of community-acquired bloodstream infection in Africa.

196 sfully treated A. oryzae catheter-associated bloodstream infection in an immunocompetent patient prio

197 cin-resistant Enterococcus (VRE), leading to bloodstream infection in hospitalized patients.

198 associated with at least 400,000 episodes of bloodstream infection in patients with cancer every year

199 nvasive candidiasis is the third most common bloodstream infection in the intensive care unit (ICU) a

200 me sequencing of E. faecalis associated with bloodstream infection in the UK and Ireland over more th

201 lso available for E. faecium associated with bloodstream infections in 15 patients in neighboring hos

202 nin both have a promising role in predicting bloodstream infections in a manner more helpful than C-r

203 ent interventions on central line-associated bloodstream infections in adult intensive care units.

204 standard central venous catheters to prevent bloodstream infections in children needing intensive car

205 Enterococci are a major cause of bloodstream infections in hospitalized patients and have

206 Candida is the third most common cause of bloodstream infections in hospitalized patients.

207 bial-resistant S. marcescens associated with bloodstream infections in hospitals across the United Ki

208 eate the impact of propofol sedation on MRSA bloodstream infections in mice in the presence and absen

209 4 most common gram-negative bacteria causing bloodstream infections in neutropenic patients.

210 central venous catheters could help prevent bloodstream infections in paediatric intensive care unit

211 illin-resistant Staphylococcus aureus (MRSA) bloodstream infections in patients with impaired renal f

212 ections and possible central line-associated bloodstream infections in preterm infants.

213 The ordering of blood cultures, bloodstream infection incidence, and ICU mortality were

214 f catheter colonization and catheter-related bloodstream infection, including arterial catheters used

215 of discrete lineages caused the majority of bloodstream infections, including one subclone (ST131-H3

216 We found no difference in catheter-related bloodstream infection (internal jugular 1.0 vs. femoral

217 Prevention of catheter-related bloodstream infection is a basic objective to optimize p

218 Bacterial bloodstream infection is a common cause of morbidity and

219 Bacteremia or bloodstream infection is a frequent and costly complicat

220 Bloodstream infection is a serious condition associated

221 Staphylococcus aureus bloodstream infection is associated with considerable mo

222 sion, these data suggest that S. epidermidis bloodstream infection is cleared in a highly efficient m

223 s a link between B. holmesii respiratory and bloodstream infection is unknown.

224 Research on S. aureus bloodstream infections is a frontier for the characteriz

225 Identification of bloodstream infections is among the most critical tasks

226 Bacteremia (bacterial bloodstream infection) is a major cause of illness and d

227 al jugular for the risks of catheter-related bloodstream infection, major catheter-related infection,

228 140 isolates of S. pneumoniae recovered from bloodstream infection (n = 70) and meningitis (n = 70) t

229 Bloodstream infection occurred in 18 (4%) of those in th

230 cal infections of >0.3/1,000 patient days or bloodstream infections of >0.03/1,000 patient days shoul

231 her catheter-related clinical sepsis without bloodstream infection or catheter-related bloodstream in

232 The development of bloodstream infection (OR: 18.76; 95% CI: 1.04-339.37; p

233 ections included pleuropneumonitis, isolated bloodstream infection, osteomyelitis, endocarditis, and

234 gdom identified 342 patients with E. faecium bloodstream infection over 7 years.

235 regression to examine trends in icidence of bloodstream infection over time.

236 colonization (P = 0.57) or catheter-related bloodstream infection (P = 0.99).

237 es in children should focus on prevention of bloodstream infections, particularly among neonates and

238 eus bloodstream infection and in 268 E. coli bloodstream infection patients, respectively (1:1 match

239 Rates of bloodstream infection per 1,000 bed-days were estimated

240 ma; any ICU-acquired infection; ICU-acquired bloodstream infection, pneumonia, and urinary tract infe

241 2013 and June 2014 with suspected or proven bloodstream infection, pneumonia, or sterile fluid and t

242 Central catheter-associated bloodstream infection prevention bundle that included da

243 ich may suggest that the catheter-associated bloodstream infection prevention program was particularl

244 hlorhexidine bathing, 4) catheter-associated bloodstream infection program, and 5) daily goals sheets

245 ent conditions increased risk of PVC-related bloodstream infection (PVCR-BSI).

246 in a reduced prevalence of catheter-related bloodstream infection (random effects relative risk, 0.6

247 The overall catheter-related bloodstream infection rate was 0.2 per 1,000 catheter da

248 Incident bloodstream infection rate was 9.6 and 8.4 per 1000 hosp

249 Central catheter-associated bloodstream infection rates and safety outcomes (central

250 d and Wales demonstrates a steady decline in bloodstream infection rates over time.

251 We assessed variation in bloodstream infection rates within and between PICUs ove

252 is situations, decreases catheter-associated bloodstream infections, reduces blood product utilizatio

253 Bloodstream infections remain a major cause of morbidity

254 ty of America definition of catheter-related bloodstream infection remains the most precise definitio

255 inical S. aureus isolates from patients with bloodstream infections, representing two globally import

256 ed pneumonia, intra-abdominal infections and bloodstream infections, respectively.

257 imens collected from patients with suspected bloodstream infections resulted in 35 PCR/ESI-MS-positiv

258 ution width is associated with mortality and bloodstream infection risk in the critically ill.

259 racteristics were excluded, catheter-related bloodstream infection risk was comparable between the si

260 Catheter-related bloodstream infection risk was comparable for internal j

261 an may, similarly, decrease catheter-related bloodstream infection risk, when compared with femoral.

262 From the 616 bloodstream infection samples, polymerase chain reaction

263 icantly greater reduction in the rate of all bloodstream infections than either targeted decolonizati

264 Klebsiella pneumoniae causes severe lung and bloodstream infections that are difficult to treat due t

265 of MRSA, highlight the growing challenge of bloodstream infections that are effectively impossible t

266 , however, at high risk for catheter-related bloodstream infections that can result in substantial mo

267 , are responsible for the majority of fungal bloodstream infections that cause morbidity, especially

268 site infections, and 2 versus 0 for primary bloodstream infection; the effect was consistent across

269 o preventing central venous catheter-related bloodstream infection to arterial catheters as well.

270 methicillin-resistant Staphylococcus aureus bloodstream infections treated with vancomycin was perfo

271 Assessment of bloodstream infection trends before as well as after imp

272 ssue infection, urinary tract infection, and bloodstream infection varied among the 3 sites.

273 omes (ICU mortality, central line-associated bloodstream infection, ventilator-associated pneumonia,

274 ile infection (CDI), central line-associated bloodstream infection, ventilator-associated pneumonia/e

275 Vancomycin-resistant Enterococcus bloodstream infections (VRE-BSIs) are associated with si

276 Vancomycin-resistant Enterococcus bloodstream infections (VRE-BSIs) are becoming increasin

277 the purposes of this study, catheter-related bloodstream infection was defined as positive blood cult

278 The total hospital cost per bloodstream infection was lower in the intervention grou

279 One bloodstream infection was prevented per 54 patients who

280 Low-dose acetylsalicylic acid at the time of bloodstream infection was strongly associated with a red

281 The overall rate of hospital-acquired bloodstream infections was 4.78 cases per 1000 patient-d

282 The number of catheter-related bloodstream infections was expressed as median and inter

283 The rate of catheter-related bloodstream infections was higher in the early-strategy

284 Trichosporon inkin, a novel organism causing bloodstream infection, was detected in 2 patients with p

285 lis is a natural heme auxotroph and cause of bloodstream infection, we explored whether restoration o

286 ter days, and prevalence of catheter-related bloodstream infection were abstracted.

287 or-associated pneumonia and catheter-related bloodstream infection were analyzed by year.

288 three episodes (313 isolates) of C. glabrata bloodstream infection were analyzed.

289 The reductions in rates of MRSA bloodstream infection were similar to those of all blood

290 A total of 480 patients with bloodstream infections were included in the analysis: 24

291 Bloodstream infections were increased in patients with v

292 Bloodstream infections were the most common type of infe

293 s activating protease in the pathogenesis of bloodstream infection, which indicates a greater complex

294 strategies for the pathogenesis of S. aureus bloodstream infections, which culminate in the establish

295 n versus baseline periods, hazard ratios for bloodstream infection with any pathogen in the three gro

296 Here we show that during a bloodstream infection with methicillin-resistant Staphyl

297 We describe a case of polymicrobial bloodstream infection with six organisms identified by m

298 A bloodstream infection with Staphylococcus aureus, includ

299 ndidaemia is the fourth most common cause of bloodstream infection, with a high mortality rate of up

300 is the single most prevalent cause of fungal bloodstream infections worldwide causing significant mor